UP-FRONT HIGH DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA - SINGLE CENTER REAL-WORLD ANALYSIS OF 165 CASES

被引：0
|
作者：
Tsukada, Nobuhiro [1 ]
Kikuchi, Taku [1 ]
Kunisada, Kodai [1 ]
Oda, Yuki [1 ]
Yogo, Moe [1 ]
Takei, Tomomi [1 ]
Sato, Kota [1 ]
Ogura, Mizuki [1 ]
Abe, Yu [1 ]
Suzuki, Kenshi [1 ]
Ishida, Tadao [1 ]
机构：
[1] Japanese Red Cross Med Ctr, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P545
引用
收藏
页码：519 / 520
页数：2
相关论文
共 50 条
  • [21] Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Srour, Samer A.
    Milton, Denai
    Bashir, Qaiser
    Mehta, Rohtesh S.
    Delgado, Ruby
    Rondon, Gabriela
    Nieto, Yago
    Hosing, Chitra M.
    Popat, Uday R.
    Ciurea, Stefan O.
    Patel, Krina
    Lee, Hans C.
    Manasanch, Elisabet
    Thomas, Sheeba
    Weber, Donna
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [22] Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma
    Eom, Ki-Seong
    Min, Chang-Ki
    Lee, Seok
    Kim, Yoo-Jin
    Kim, Sung-Yong
    Kim, Hee-Je
    Lee, Jong-Wook
    Min, Woo-Sung
    Kim, Chun-Choo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (07) : 432 - 438
  • [23] REAL-WORLD OUTCOMES OF UPFRONT AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH DEL (17P)
    Marcoux, Curtis
    Pasvolsky, Oren
    Milton, Denai R.
    Khan, Hina
    Tanner, Mark R.
    Ahmed, Amna
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Aljawai, Yosra
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BONE MARROW TRANSPLANTATION, 2024, 59 : 512 - 513
  • [24] Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p
    Marcoux, Curtis
    Pasvolsky, Oren
    Milton, Denaii R.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Tang, Guilin
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Ahmed, Amna
    Aljawai, Yosra
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (01): : 12e1 - 12e10
  • [25] Full dose or reduced dose Melphalan (MEL) for autologous stem cell transplantation (ASCT) in multiple myeloma (MM): a single center analysis on 146 patients
    vom Hofe, F.
    Muegge, L-O
    Scholl, S.
    Hilgendorf, I
    Sayer, H.
    Yomade, O.
    Ernst, T.
    Hochhaus, A.
    von Lilienfeld-Toal, M.
    Brioli, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 184 - 184
  • [26] COMPARISON OF LONG VS SHORT SURVIVORS AFTER UP-FRONT AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Remes, K.
    Salminen, M.
    Putkonen, M.
    Kauko, T.
    Kauppila, M.
    Salmenniemi, U.
    Salmi, T.
    Itala-Remes, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S454 - S454
  • [27] Autologous haematopoietic stem cell transplantation as an up-front therapy in stage III multiple myeloma: The Lebanese experience
    Ibrahim, A.
    Otrock, Z.
    Mugharbel, A.
    Mahfouz, R.
    Salem, Z.
    Shebbo, W.
    Hatoum, H.
    Nsouli, G.
    Shamseddine, A.
    Jalloul, R.
    Taher, A.
    El-Saghir, N.
    Baz, E.
    Makarem, J.
    El-Kinge, A.
    Droubi, N.
    Kreidieh, N.
    Yassine, N.
    Jisr, T.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S159 - S159
  • [28] Treatment of Newly Diagnosed Multiple Myeloma: A Real-world Study in A Western Single Center of China
    Liao, Yi
    Wang, Zhongwang
    Niu, Ting
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E230 - E230
  • [29] Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience
    Chong, Yong Pil
    Kim, Shin
    Ko, Ok Bae
    Koo, Ja Eun
    Lee, Danbi
    Park, Sang Hyoung
    Park, Soo Jung
    Lee, Daeho
    Kim, Sang We
    Suh, Cheolwon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (05) : 819 - 824
  • [30] INCORPORATION OF THALIDOMIDE INTO UP-FRONT DOUBLE AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA FAILS TO OVERCOME THE POOR PROGNOSIS IMPARTED BY CHROMOSOME 13 DELETION
    Cavo, M.
    Terragna, C.
    Testoni, N.
    Tosi, P.
    Ceccolini, M.
    Gorgone, A.
    Annunziata, S.
    Nicci, C.
    Renzulli, M.
    Fattori, P. P.
    Leopardi, G.
    Zamagni, E.
    Tacchetti, P.
    Perrone, G.
    Ronconi, S.
    Lazzaro, A.
    Offidani, M.
    Fiacchini, M.
    Vertone, D.
    Fabbri, P.
    Brioli, A.
    Pallotti, M.
    Pantani, L.
    Guardigni, L.
    Mamone, D.
    Baccarani, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 82 - 83
12345